Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CHRW | Common Stock | Options Exercise | $1.47M | +19.8K | +55.8% | $74.57 | 55.2K | Dec 7, 2021 | Direct | F1 |
transaction | CHRW | Common Stock | Sale | -$1.98M | -19.8K | -35.81% | $100.00 | 35.4K | Dec 7, 2021 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CHRW | Stock Option (right to buy) | Options Exercise | $0 | -19.8K | -100% | $0.00* | 0 | Dec 7, 2021 | Common Stock | 19.8K | $74.57 | Direct | F1, F4 |
Id | Content |
---|---|
F1 | Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021. |
F2 | Included in this amount are 28,957 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares and restricted stock units credited to the reporting person's NQDC Plan account, and 5,176 shares held directly by the reporting person. |
F3 | Includes 1,309 shares acquired pursuant to the Issuer's employee stock purchase plan. |
F4 | Fully vested. |